Single-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 827

NCT00867100 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

84

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriasis

Interventions

DRUG: 700 mg IV
DRUG: 350 mg SC
DRUG: Placebo
DRUG: 140 mg SC

Sponsor

Bausch Health Americas, Inc.